Alamar Biosciences ALMR 深 沪
等待开盘 09-30 09:30:00 美东时间
32.65
+0.040
+0.12%
华盛通- 最 高33.595
- 今 开32.43
- 成交量 109.05万股
- 最 低 32.18
- 昨 收 32.61
- 总市值 22.66亿
- 52周最高 38.54
- 市盈率 静 --
- 换手率 1.57%
- 52周最低 18.845
- 委 比 -0.50%
- 总股本 6939.28万
- 历史最高 38.54
- 量 比 2.94
- 振 幅 4.34%
- 历史最低 18.845
- 每 手 1
- 风险率 4.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
A study published in *The Lancet Neurology* reveals that blood biomarkers related to amyloid clearance differ from those linked to cognitive decline in Alzheimer's patients treated with lecanemab. The research, led by Washington University School of Medicine and using Alamar Biosciences' NULISAseq™ CNS 120 panel, analyzed 130 plasma proteins in 1,967 participants. It found that amyloid clearance and cognitive response reflect distinct biological ...
09-24 22:51
Mistras Group, Strategy, Hyperliquid Strategies And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Dow Jones index falling around 150 points on Friday. Shares of Mistras Group Inc (NYSE:MG) rose sharply during Friday’s session after the company agreed to be acquired by affiliates of H.I.G. Capital in an all-cash transaction. Under the terms of the deal, MG’s stock...
09-18 22:01
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
Alamar Biosciences, Inc. will participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York on September 15. The company's management will engage in a fireside chat at 4:05 p.m. Eastern Time. Interested parties can access the live or archived webcast via the company's investor website. Alamar specializes in precision proteomics, utilizing its proprietary NULISA™ technology and ARGO™ HT System to detect protein biomarkers ...
09-01 20:05
Top 3 Health Care Stocks That May Implode In August
As of Aug. 12, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices ...
08-12 20:58
美股牛股 | 绩优股普升！量子计算股昆腾飙升64%，NIQ劲升42%
绩优股普升！量子计算公司昆腾飙升64%，近三年来首度非GAAP单季盈利；NIQ劲升42%，Q2 EPS扭亏大幅增长；Fermi升逾21%，签署大规模AI数据中心长期租约>>
08-12 15:54
美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
JP Morgan Maintains Overweight on Alamar Biosciences, Raises Price Target to $35
JP Morgan analyst Casey Woodring maintains Alamar Biosciences (NASDAQ:ALMR) with a Overweight and raises the price target from $32 to $35.
08-11 22:09
Quantum, Kopin, Alamar Biosciences And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining around 150 points on Tuesday. Shares of Quantum Corp (NASDAQ:QMCO) rose sharply during Tuesday’s session after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates. Quantu...
08-11 22:08
Alamar Biosciences Sees FY2026 Sales $116.000M-$120.000M vs $113.259M Est
Alamar Biosciences (NASDAQ:ALMR) sees FY2026 sales of $116.000 million-$120.000 million vs $113.259 million analyst estimate.
08-11 04:42
Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures
Alamar Biosciences expands its partnership with Alzheimer's Disease Data Initiative and Gates Ventures, adding 86,000 plasma samples using NULISAseq™ Neuro 220 to study neurodegenerative disease heterogeneity. The combined dataset, expected to include over 140,000 samples by 2027, aims to provide deeper insights into disease subtypes and trajectories through multiplex protein profiling.
08-10 20:03
